ProfileGDS4718 / 204894_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 56% 60% 98% 48% 69% 44% 49% 53% 69% 60% 66% 58% 49% 57% 42% 81% 63% 53% 39% 67% 60% 61% 66% 64% 58% 48% 68% 53% 55% 38% 48% 85% 58% 43% 74% 53% 42% 61% 55% 97% 58% 47% 85% 47% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.8868956
GSM549102patient 115, normal, homogenized [OPG study]6.1151560
GSM549104patient 119, normal, homogenized [OPG study]11.228298
GSM549108patient 138, normal, homogenized [OPG study]5.437448
GSM549119patient 077, normal, homogenized [OPG study]6.7428369
GSM549133patient 032, cancer, homogenized [OPG study]5.1087144
GSM549139patient 042, cancer, homogenized [OPG study]5.4578149
GSM549099patient 107, normal, homogenized [OPG study]5.6908453
GSM549109patient 139, normal, homogenized [OPG study]6.8022169
GSM549110patient 046, normal, homogenized [OPG study]6.0993260
GSM549114patient 063, normal, homogenized [OPG study]6.5457666
GSM549122patient 082, normal, homogenized [OPG study]6.0434358
GSM549134patient 033, cancer, homogenized [OPG study]5.4385949
GSM549136patient 036, cancer, homogenized [OPG study]5.9219357
GSM549140patient 044, cancer, homogenized [OPG study]5.0556142
GSM549111patient 047, normal, homogenized [OPG study]8.0627581
GSM549113patient 057, normal, homogenized [OPG study]6.3245463
GSM549132patient 031, cancer, homogenized [OPG study]5.6703653
GSM549137patient 038, cancer, homogenized [OPG study]4.9158839
GSM549142patient 047, cancer, homogenized [OPG study]6.6554667
GSM549100patient 110, normal, homogenized [OPG study]6.118860
GSM549107patient 135, normal, homogenized [OPG study]6.1974661
GSM549115patient 068, normal, homogenized [OPG study]6.5747466
GSM549116patient 072, normal, homogenized [OPG study]6.3877964
GSM549120patient 078, normal, homogenized [OPG study]5.9914658
GSM549131patient 030, cancer, homogenized [OPG study]5.3673348
GSM549118patient 074, normal, homogenized [OPG study]6.7443868
GSM549129patient 027, cancer, homogenized [OPG study]5.678953
GSM549123patient 088, normal, homogenized [OPG study]5.7728755
GSM549124patient 006, cancer, homogenized [OPG study]4.9123438
GSM549126patient 015, cancer, homogenized [OPG study]5.4077148
GSM549128patient 025, cancer, homogenized [OPG study]8.489985
GSM549103patient 117, normal, homogenized [OPG study]6.0196958
GSM549117patient 073, normal, homogenized [OPG study]5.0818943
GSM549138patient 041, cancer, homogenized [OPG study]7.2712874
GSM549141patient 045, cancer, homogenized [OPG study]5.6785453
GSM549130patient 028, cancer, homogenized [OPG study]5.1054842
GSM549101patient 111, normal, homogenized [OPG study]6.1975361
GSM549105patient 128, normal, homogenized [OPG study]5.8008155
GSM549106patient 134, normal, homogenized [OPG study]10.938997
GSM549112patient 048, normal, homogenized [OPG study]6.0015658
GSM549125patient 011, cancer, homogenized [OPG study]5.3741947
GSM549127patient 024, cancer, homogenized [OPG study]8.394585
GSM549135patient 035, cancer, homogenized [OPG study]5.2886747